Metrics as of 10/13/2026, 06:46 PM (Berlin time), refresh in progress.
STAAR Surgical Company Stock
STAAR Surgical Company
Company data
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Country
- United States
- CEO
- Warren Foust
- Employees
- 921
- Market cap
- $1.1 B
- IPO
- 24/02/1992
STAAR Surgical Company, along with its subsidiaries, specializes in ophthalmological solutions, focusing on the design, development, manufacturing, and commercialization of implantable lenses for vision correction, complete with the sophisticated delivery systems necessary for their implantation. A core offering is…
STAAR Surgical Company stock: price history
1D
-1.5%
1W
-2.1%
1M
-4.3%
6M
-11.2%
YTD
-6.1%
1Y
-20.4%
2Y
-31.4%
5Y
-81.3%
10Y
+135.8%
Next earnings date
Next earnings date
04/11/2026 (in 18 days)
Volatility around earnings
~66% stronger price swings than usual
Ask the agents about STAAR Surgical Company
Analyst assessment of STAAR Surgical Company
PRICE TARGET LOW
US$23.00
CONSENSUS
US$30.89
MEDIAN
US$31.00
PRICE TARGET HIGH
US$40.00
0
STRONG BUY
5
BUY
9
HOLD
2
SELL
0
STRONG SELL
16
TOTAL · Hold
As of: 29/09/2026
STAAR Surgical Company stock metrics
P/E
271.19
P/B
2.99
EV/EBITDA
29.23
RETURN ON EQUITY
2.2%
NET MARGIN
8.6%
DEBT/EQUITY
0.1
DIVIDEND YIELD
0.0%
AS OF
03/07/2026
Free float & liquidity
FREE FLOAT
99.2%
FLOAT SHARES
49,390,684
AVG. DAILY VOLUME (30D)
988,256
Insider transactions (SEC)
Michna Magda
Foust Warren
ANDREWS DEBORAH J
ANDREWS DEBORAH J
Michna Magda
Attention
1 mention today in US forums, about the same as yesterdayPrice since yesterday: -1.5%
Forums (Reddit)
Institutional holders
Dividends & Stock splits
Comparable stocks
Frequently asked questions about STAAR Surgical Company stock
What does STAAR Surgical Company do?
STAAR Surgical Company is a company in the Healthcare sector, Medical - Instruments & Supplies industry, headquartered in United States.
The CEO is Warren Foust, the company employs around 921 people.
The IPO was on 24/02/1992; the stock trades on NASDAQ under the ticker STAA.
What do analysts say about STAAR Surgical Company stock?
16 analysts rate the stock, the consensus is Hold (as of 29/09/2026).
The average price target is US$30.89, ranging from US$23.00 to US$40.00, with a median of US$31.00.
This is an external assessment, not a statement by Market Jury.
When does STAAR Surgical Company report next?
The next earnings date is 04/11/2026.
Around past earnings, price swings were roughly 66% stronger than usual.
Does STAAR Surgical Company pay a dividend?
No, STAAR Surgical Company currently does not pay a dividend.
Which stocks are comparable to STAAR Surgical Company?
Comparable stocks include Intuitive Surgical, Becton, Dickinson and Company, ResMed, West Pharmaceutical Services, Solventum, Baxter International, Cooper Companies and Avantor.
How can I get STAAR Surgical Company stock analyzed?
Clicking "Analyze stock" lets five strategies assess STAAR Surgical Company against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.